Pipeline Embolization Device for the Treatment of Intracranial Aneurysms on the Long Term Safety and Efficacy

Launched by XUANWU HOSPITAL, BEIJING · Jun 10, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the long-term safety and effectiveness of a device called the Pipeline Embolization Device (PED), which is used to treat intracranial aneurysms—bulges in blood vessels in the brain that can be dangerous. Since this device has been used in China since 2014, researchers want to gather more information on how well it works over time and how safe it is for patients.

To participate in this trial, patients need to have been diagnosed with an intracranial aneurysm using a specific imaging test called digital subtraction angiography. They should also have had the PED successfully placed to treat their aneurysm. However, patients who have had previous surgery or other treatments for their aneurysms or who cannot complete follow-up visits will not be eligible. If you join the study, you can expect regular check-ups to monitor your health and the effectiveness of the device over the long term. This research is important as it will help doctors understand how to best use the PIPELINE device in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. The patient was diagnosed with intracranial aneurysms using digital subtraction angiography (DSA).
• • 2. The pipeline was successfully placed to treat intracranial aneurysms.
• Exclusion Criteria:
• • 1. Patients had undergone surgery or interventional treatment before enrollment.
• • 2. During treatment, other types of stents are used in combination.
• • 3. Unable to complete the follow-up.